Mary M. Rozenman, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 45,060 shares at $20.57 ($939K) on 2017-07-03, disclosed to the SEC on 2017-07-06.
Open-market sale of $939k AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.57 | 30,000 | $617K | 65.7% |
| 2 | $21.40 | 15,060 | $322K | 34.3% |
| Total | $20.85 avg | 45,060 | $939K | 100% |
| Filing → |
| AIMT | SELL | 2018-01-04 | $489K | — | Filing → |
| AIMT | SELL | 2017-12-28 | $381K | — | Filing → |
| AIMT | SELL | 2017-09-11 | $675K | — | Filing → |